YOLFTbeta
BLUEMTEC Co., Ltd.

BLUEMTEC Co., Ltd.

439580 · KQ · Healthcare / Pharmaceutical Retailers

1,824.00KRW-60.00 (-3.18%)

Price History

Full chart

Market Stats

Previous Close1,884.00
Open1,884.00
Day Range1,808.00 – 2,060.00
52-Week Range1,341.00 – 5,740.00
Volume231.73K
Market Cap100.69B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.70
50-Day Avg2,089.80
200-Day Avg3,042.57

About

BLUEMTEC Co., Ltd. operates a pharmaceutical distribution platform in South Korea and internationally. It is also involved in the healthcare digital marketing, IT development, fulfilment, pharmaceutical distribution data, and medical staff matching, and logistics businesses. The company was founded in 2015 and is headquartered in Yongin-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Hyunsu Kim
  • Employees92
  • Headquarters#1612, A-dong, Hicks U Tower, Yongin-si, South Korea, Korea
  • Websitehttps://bluemtec.com

Leadership

  • Mr. Hyunsu KimCEO & Director · b. 1975
  • Mr. Jeryang YeonPresident & Director · b. 1975

Financials

Income Statement

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue51.87B77.15B113.85B133.29B185.91B
Growth (%)-+48.72%+47.58%+17.07%+39.48%
Cost of Revenue45.33B64.11B99.66B119.98B167.27B
Gross Profit6.54B13.03B14.20B13.30B18.63B
Gross Margin12.62%16.89%12.47%9.98%10.02%
Operating Expense9.26B12.14B12.85B20.20B20.60B
Operating Income-2.71B890.61M1.34B-6.90B-1.97B
Operating Margin-5.23%1.15%1.18%-5.17%-1.06%
EBITDA--12.66B-1.47B-662.17M1.21B
EBITDA Margin--16.41%-1.29%-0.50%0.65%
Net Income-7.62B-14.24B-2.34B-4.80B-4.51B
Net Income Margin-14.69%-18.45%-2.06%-3.60%-2.43%
R&D435.24M499.44M649.49M1.33B1.55B
R&D as % of Total Revenue0.84%0.65%0.57%1.00%0.84%
Interest Expense736.28M1.31B21.35M83.78M3.24B
Interest Expense % of Total Revenue1.42%1.70%0.02%0.06%1.74%

Balance Sheet

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets25.63B40.36B92.24B115.66B109.96B
Total Liabilities31.97B39.18B46.82B68.53B65.13B
Total Equity-6.52B1.18B45.41B47.14B44.84B
Cash8.39B7.61B28.04B15.65B10.93B
Net Debt-2.93B2.06B17.60B21.82B

Cash Flow

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.75B-541.23M-1.11B-12.24B5.01B
Investing Cash Flow--9.98B-23.74B-15.91B-
Financing Cash Flow-9.74B45.28B15.76B-
Capital Expenditure6.57B8.92B20.76B2.52B1.97B
Free Cash Flow-10.32B-9.46B-21.87B-14.76B3.04B
FCF to OCF275.23%1748.22%1973.85%120.56%60.71%

Earnings

Report DateDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------
EPS Actual-71.74-47.2575.62-104.34-57.98-48.02-103.20-14.532.3578.0758.49
Surprise-----------
Timing-----------

Key Statistics & Ratios

Market Cap100.69B
Enterprise Value120.06B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.49
Price / Book1.86
Revenue (TTM)205.08B
Gross Profit (TTM)18.18B
EBITDA1.51B
Profit Margin2.05%
Operating Margin0.33%
Return on Equity9.17%
Return on Assets-0.39%
Shares Outstanding33.85M
Shares Float21.86M
Beta0.70
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 8, 20253:1